Altre lingue Universe Pharmaceuticals INC

Azioni

UPC

KYG9442G1120

Mercato chiuso - Nasdaq Altri mercati azionari 22:30:00 20/06/2024			Variaz. 5gg	Var. 1 gen.
2,318 ^USD	+0,78%		-3,42%	+15,32%

30/01	Universe Pharmaceuticals INC riporta i risultati degli utili per l'intero anno terminato il 30 settembre 2023	CI
2023	I migliori guadagni del mercato premarket	MT

Altre lingue

Sblocca tutte le notizie su tutte le aziende: non perdere mai più un'opportunità di investimento redditizia!

Registrazione 100% gratuita

Top Premarket Decliners	15/04
Universe Pharmaceuticals INC Reports Fiscal Year 2023 Financial Results	30/01
Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2023	30/01
Top Premarket Gainers	11/09/23
Universe Pharmaceuticals INC Reports Earnings Results for the Half Year Ended March 31, 2023	31/08/23
Universe Pharmaceuticals : Receipt of Nasdaq Notification Regarding Compliance with Nasdaq Minimum Bid Price Requirement - Form 6-K	16/08/23
Universe Pharmaceuticals Receives Nasdaq Non-Compliance Notice	04/08/23
Universe Pharmaceuticals INC Announces Receipt of Nasdaq Notification Regarding Minimum Market Value of Publicly Held Shares	04/08/23
Universe Pharmaceuticals INC Announces Share Consolidation	27/07/23
Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2023 Annual General Meeting - Form 6-K	05/07/23
Universe Pharmaceuticals INC Announces Board Changes	05/05/23
Universe Pharmaceuticals INC Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency	07/03/23
Universe Pharmaceuticals INC Reports Earnings Results for the Full Year Ended September 30, 2022	10/02/23
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19	21/12/22
Universe Pharmaceuticals INC Announces Inclusion of Six Products into the First Edition of Catalogue of Medicine for Patients Infected with COVID-19	21/12/22
Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement	14/11/22
Universe Pharmaceuticals INC Regains Compliance with Nasdaq Minimum Bid Price Requirement	14/11/22
Universe Pharmaceuticals : Results of the Universe Pharmaceuticals INC 2022 Annual General Meeting - Form 6-K	28/09/22
Universe Pharmaceuticals INC Reports Earnings Results for the Half Year Ended March 31, 2022	16/08/22
Universe Pharmaceuticals INC Reports Financial Results for The First Six Months of Fiscal Year 2022	16/08/22

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Resoconti Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Altre lingue Universe Pharmaceuticals INC

Azioni

UPC

KYG9442G1120

Altre lingue

Filtri